Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Metabolic syndrome and diabetes for the urologist.

Literature DB >> 25243043

Metabolic syndrome and diabetes for the urologist.

Abstract

Type 2 diabetes has a number of know urological consequences. Epidemiologic and clinical data suggest a link between metabolic syndrome and prostatic diseases, such as benign prostatic hyperplasia (BPH) and prostate cancer. Recent studies have identified metformin as a viable treatment for patients with type 2 diabetes and prostate cancer.

Entities: Chemical Disease Species

Year: 2014 PMID： 25243043 PMCID： PMC4145702 DOI： 10.5489/cuaj.2314

Source DB: PubMed Journal: Can Urol Assoc J ISSN： 1911-6470 Impact factor: 1.862

17 in total

1. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors:
Journal: JAMA Date: 2001-05-16 Impact factor: 56.272

2. The metabolic syndrome--a new worldwide definition.

Authors: K George M M Alberti; Paul Zimmet; Jonathan Shaw
Journal: Lancet Date: 2005 Sep 24-30 Impact factor: 79.321

Review 3. Metabolic complications of androgen deprivation therapy for prostate cancer.

Authors: Philip J Saylor; Matthew R Smith
Journal: J Urol Date: 2013-01 Impact factor: 7.450

Review 4. Male sexual dysfunction and infertility associated with neurological disorders.

Authors: Mikkel Fode; Sheila Krogh-Jespersen; Nancy L Brackett; Dana A Ohl; Charles M Lynne; Jens Sønksen
Journal: Asian J Androl Date: 2011-12-05 Impact factor: 3.285

Review 5. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis.

Authors: Salvatore Mottillo; Kristian B Filion; Jacques Genest; Lawrence Joseph; Louise Pilote; Paul Poirier; Stéphane Rinfret; Ernesto L Schiffrin; Mark J Eisenberg
Journal: J Am Coll Cardiol Date: 2010-09-28 Impact factor: 24.094

6. Association between metformin use and risk of prostate cancer and its grade.

Authors: David Margel; David Urbach; Lorraine L Lipscombe; Chaim M Bell; Girish Kulkarni; Peter C Austin; Neil Fleshner
Journal: J Natl Cancer Inst Date: 2013-07-13 Impact factor: 13.506

7. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors: K G Alberti; P Z Zimmet
Journal: Diabet Med Date: 1998-07 Impact factor: 4.359

8. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.

Authors: K G M M Alberti; Robert H Eckel; Scott M Grundy; Paul Z Zimmet; James I Cleeman; Karen A Donato; Jean-Charles Fruchart; W Philip T James; Catherine M Loria; Sidney C Smith
Journal: Circulation Date: 2009-10-05 Impact factor: 29.690

9. Inflammatory markers and risk of developing type 2 diabetes in women.

Authors: Frank B Hu; James B Meigs; Tricia Y Li; Nader Rifai; JoAnn E Manson
Journal: Diabetes Date: 2004-03 Impact factor: 9.461

Review 10. AMPK, insulin resistance, and the metabolic syndrome.

Authors: Neil B Ruderman; David Carling; Marc Prentki; José M Cacicedo
Journal: J Clin Invest Date: 2013-07-01 Impact factor: 14.808

4 in total

Review 1. Metabesity and urological cancers.

Authors: Ali Atan
Journal: Turk J Urol Date: 2017-12-01